MetaVia Inc.
MTVANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MTVA. That does not mean none is planned.
Get an email about MTVA's next catalysts
Track MetaVia (MTVA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 2 past
MTVA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.94 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Obesity
1 drug in this indication
obesity / metabolic disease (weight loss, liver fat reduction)
1 drug in this indication
MetALD and ALD (metabolic dysfunction and alcohol-associated liver disease)
1 drug in this indication
MetALD (metabolic dysfunction-associated alcohol-related liver disease)
1 drug in this indication
MetALD and ALD (liver-related cardiometabolic diseases); obesity
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is MetaVia Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for MetaVia Inc. (MTVA) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track MTVA biotech catalysts?β
Add MTVA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MetaVia Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
